Silver Book Fact

A study looking at the effects of cardiovascular medicines in elderly patients who had previous heart attacks, found a total death rate reduction of 24% between 1995 and 2004.

Setoguchi S, Glynn R, Avorn J, Mittleman M, et al. Improvements in Long-Term Mortality After Myocardial Infarction and Increased Use of Cardiovascular Drugs After Discharge: A 10-year trend analysis. JACC. 2008; 51(13): 1247-54. http://content.onlinejacc.org/cgi/content/abstract/51/13/1247?maxtoshow=&HITS=10&hits=10&RESULTFORMAT=&author1=Setoguchi&fulltext=Improvements+in+long-term+mortality&andorexactfulltext=and&searchid=1&FIRSTINDEX=0&sortspec=relevance&resourcetype=HW

Reference

Title
Improvements in Long-Term Mortality After Myocardial Infarction and Increased Use of Cardiovascular Drugs After Discharge: A 10-year trend analysis
Publication
JACC
Publication Date
2008
Authors
Setoguchi S, Glynn R, Avorn J, Mittleman M, et al
Volume & Issue
Volume 51, Issue 13
Pages
1247-54
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Human Value

Related Facts

  • Using medical imaging to diagnose and treat stroke leads to better outcomes and shorter hospital stays, which yields a net economic benefit of about $8 billion over 10 years.  
  • There are 23 medicines in development for stroke, the third leading cause of death after heart disease and cancer.  
  • Cost-savings associated with Warfarin use in AFib patients
    Warfarin use in Medicare patients with nonvalvular atrial fibrillation was independently associated with lower medical costs averaging $9,836 per patient, per year.  
  • Antihypertensive Medicines Have Prevented Deaths and Hospitalizations: Study quantified impact of high blood pressure drugs on the U.S. population 1999-2000  
  • The rise in beta-blocker treatment rates (34% since 1996) is proof that sustained attention and effective initiatives saves lives and improves quality of life.